Kymera Therapeutics (KYMR) Retained Earnings (2019 - 2026)
Kymera Therapeutics (KYMR) reported Retained Earnings of -$4.2 million for Q1 2026, up 99.49% year-over-year from -$2.1 million in Q1 2025, and down 333.0% quarter-over-quarter from $1.8 million in Q4 2025.
Kymera Therapeutics (KYMR) Retained Earnings (2019 - 2026) Analysis & Trends
Kymera Therapeutics (KYMR) has 8 years of Retained Earnings data on file, last reported at -$4.2 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$4.2 million, up 99.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.2 million (up 99.49% YoY), and the FY2025 annual result was $1.8 million, up 221.21% from the prior year.
- Retained Earnings retreated to -$4.2 million in Q1 2026 per KYMR's latest filing, from $1.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at $1.9 million in Q3 2024 and troughed at -$979.0 million in Q3 2025.
- A 5-year average of -$262.0 million and a median of -$4.2 million in 2026 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 221.21% in 2025 and fell as far as 50798.08% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$4.9 million in 2022, then surged by 88.85% to -$552000.0 in 2023, then plunged by 169.02% to -$1.5 million in 2024, then soared by 221.21% to $1.8 million in 2025, then slumped by 333.0% to -$4.2 million in 2026.
- Business Quant data shows KYMR's Retained Earnings at -$4.2 million in Q1 2026, $1.8 million in Q4 2025, and -$979.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Kymera Therapeutics | 8.84 Bn | 8.19 Bn | - | -4.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.19 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | -978.98 Mn |
| Jun 30, 2025 | -896.80 Mn |
| Mar 31, 2025 | -820.19 Mn |
| Dec 31, 2024 | -1.49 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | -621.40 Mn |
| Mar 31, 2024 | -1.78 Mn |
| Dec 31, 2023 | -552,000.00 |
| Sep 30, 2023 | -2.45 Mn |
| Jun 30, 2023 | -463.52 Mn |
| Mar 31, 2023 | -3.04 Mn |
| Dec 31, 2022 | -4.95 Mn |
| Sep 30, 2022 | -348.93 Mn |
| Jun 30, 2022 | -305.92 Mn |
| Mar 31, 2022 | -3.22 Mn |
| Dec 31, 2021 | -228.98 Mn |
| Sep 30, 2021 | -195.08 Mn |
| Jun 30, 2021 | -166.50 Mn |